Christopher Wilson

Senior Associate

Christopher Wilson

Washington, D.C.

P: +1.202.639.7739
F: +1.202.585.1058
  • Representing major pharmaceutical company in in antitrust class action involving a blockbuster biologic drug, where class plaintiffs have alleged reverse-payment settlement agreements between the brand and biosimilar manufacturers, and also that the brand amassed a "patent thicket" of over 100 patents that forestalled competition.
  • Representing major generic pharmaceutical companies in one of the largest-ever antitrust class actions, currently pending as multi-district litigation brought by state attorneys general, individual, direct action plaintiffs, and putative classes of direct, intermediate, and end purchaser plaintiffs.
  • Representing major generic pharmaceutical company in antitrust action brought in involving alleged sham litigation and misuse of Hatch-Waxman regulatory scheme.
  • Represented industrial manufacturer in a class action alleging a Section 1 price-fixing conspiracy;  granted a favorable ruling on summary judgment, which was affirmed on appeal.
  • Represented healthcare manufacturers in a class action alleging a Section 1 price-fixing conspiracy; granted a favorable judgment on a motion to dismiss the original consolidated complaint.
  • Represented generic pharmaceutical manufacturers in Hatch-Waxman Act litigation; was deeply involved in negotiating settlements as well as in representing clients through trial.
  • Represented manufacturer in a civil action that initially asserted antitrust and various common law claims; the plaintiff voluntarily dismissed the antitrust claim rather than responding to a motion to dismiss directed to that claim.
  • Represented a mother and child in a pro bono action against a state department of family services, alleging violations of the mother's and child's constitutional rights; granted a six-figure monetary settlement for the mother and child, as well as extensive policy changes within the state department.